Cargando…

Myostatin and Insulin-Like Growth Factor I: Potential Therapeutic Biomarkers for Pompe Disease

OBJECTIVE: Myostatin and insulin-like growth factor 1 (IGF-1) are serum markers for muscle growth and regeneration. However, their value in the clinical monitoring of Pompe disease – a muscle glycogen storage disease – is not known. In order to evaluate their possible utility for disease monitoring,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Yin-Hsiu, Han, Der-Sheng, Hwu, Wuh-Liang, Thurberg, Beth L., Yang, Wei-Shiung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743802/ https://www.ncbi.nlm.nih.gov/pubmed/23967261 http://dx.doi.org/10.1371/journal.pone.0071900

Ejemplares similares

Development of Newborn Screening for Pompe Disease
por: Hwu, Wuh-Liang, et al.
Publicado: (2020)

A review of treatment of Pompe disease in infants
por: Chien, Yin-Hsiu, et al.
Publicado: (2007)

The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
por: Chiang, Shu-Chuan, et al.
Publicado: (2020)

Serum reference value of two potential doping candidates—myostatin and insulin-like growth factor-I in the healthy young male
por: Han, Der-Sheng, et al.
Publicado: (2017)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
por: Chien, Yin-Hsiu, et al.
Publicado: (2017)

Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study
por: Peng, Steven Shinn-Forng, et al.
Publicado: (2016)

The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients
por: Feeney, Erin J, et al.
Publicado: (2014)

A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Lee, Ni-Chung, et al.
Publicado: (2017)

A pilot study shows the positive effects of continuous airway pressure for treating hypernasal speech in children with infantile-onset Pompe disease
por: Zeng, Yin-Ting, et al.
Publicado: (2021)

Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
por: Chien, Yin-Hsiu, et al.
Publicado: (2020)

Ultrastructural and diffusion tensor imaging studies reveal axon abnormalities in Pompe disease mice
por: Lee, Ni-Chung, et al.
Publicado: (2020)

Performance of the Four-Plex Tandem Mass Spectrometry Lysosomal Storage Disease Newborn Screening Test: The Necessity of Adding a 2nd Tier Test for Pompe Disease
por: Chiang, Shu-Chuan, et al.
Publicado: (2018)

STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa
por: Gutschmidt, Kristina, et al.
Publicado: (2021)

Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation
por: Chen, Chun-An, et al.
Publicado: (2005)

Precocious puberty in patients with Pompe disease
por: Tsai, Meng-Ju Melody, et al.
Publicado: (2023)

Serum Myostatin Is Reduced in Individuals with Metabolic Syndrome
por: Han, Der-Sheng, et al.
Publicado: (2014)

Association between Sarcopenia and Insulin-Like Growth Factor-1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis
por: Widajanti, Novira, et al.
Publicado: (2022)

GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry
por: Reuser, Arnold J. J., et al.
Publicado: (2019)

Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population
por: Chen, Szu‐Ju, et al.
Publicado: (2019)

Eye anomalies and neurological manifestations in patients with PAX6 mutations
por: Chien, Yin-Hsuan, et al.
Publicado: (2009)

Novel Compound Heterozygous Variants in TBCD Gene Associated with Infantile Neurodegenerative Encephalopathy
por: Chen, Chih-Ling, et al.
Publicado: (2021)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
por: Mariot, Virginie, et al.
Publicado: (2017)

Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
por: Hsu, Rai-Hseng, et al.
Publicado: (2023)

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency
por: Tai, Chun-Hwei, et al.
Publicado: (2022)

Myostatin inhibition therapy for insulin-deficient type 1 diabetes
por: Coleman, Samantha K., et al.
Publicado: (2016)

Development of antisense-mediated myostatin knockdown for the treatment of insulin resistance
por: Eilers, Wouter, et al.
Publicado: (2021)

Dietary intake and nutritional status of patients with phenylketonuria in Taiwan
por: Weng, Hui-Ling, et al.
Publicado: (2020)

Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin‐Deficient Diabetic Mice
por: Bunn, R Clay, et al.
Publicado: (2023)

Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report
por: Thurberg, Beth L.
Publicado: (2020)

Curated incidence of lysosomal storage diseases from the Taiwan Biobank
por: Tsai, Meng-Ju Melody, et al.
Publicado: (2023)

Myostatin: a potential therapeutic target for metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
por: Lin, Han-Yi, et al.
Publicado: (2022)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

Electrical Abnormalities in Dopaminergic Neurons of the Substantia Nigra in Mice With an Aromatic L-Amino Acid Decarboxylase Deficiency
por: Ho, Shih-Yin, et al.
Publicado: (2019)

Inhibition of myostatin signaling increases glucose in insulin-deficient diabetic mice
por: Wang, Qian, et al.
Publicado: (2012)

High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan
por: Chen, Hui-An, et al.
Publicado: (2022)

Aromatic l‐amino acid decarboxylase deficiency in Taiwan
por: Hwu, Wuh‐Liang, et al.
Publicado: (2023)

Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview
por: Stevens, David, et al.
Publicado: (2022)

Hearing in adults with Pompe disease
por: van der Beek, Nadine A. M. E., et al.
Publicado: (2011)

Targeted Editing of Myostatin Gene in Sheep by Transcription Activator-like Effector Nucleases
por: Zhao, Xinxia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tihc16tuhqdvg5cjns6tk011f4